Insights
Climate action is health action: OHE’s focus on sustainability
22 July 2025
At the intersection of health and the climate is an urgent crisis. This crisis affects health in ways that are wide-ranging, unevenly distributed, and difficult to isolate. It poses deep challenges not only for service delivery but for how we define value, whose preferences we measure, and how we account for intergenerational and regional equity.
From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
21 July 2025
Antimicrobial resistance (AMR) is an urgent global health crisis. AMR infections cause an estimated 1.3 million deaths globally every year, and this number is only projected to rise.
Reflections from the Region: Healthcare transformation in the Middle East
18 June 2025
It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is happening across the Middle East.
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most Favoured Nation’ drug pricing. We know that…
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
11 June 2025
As healthcare systems strive to allocate resources efficiently, the use of economic evaluation metrics like Quality-Adjusted Life Years (QALYs) has become increasingly important.
Around the world in HTAs: Argentina – Long Road to Institutionalizing HTA
9 June 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés Pichon-Riviere, Federico Augustovski, and Martina Garau take us to Argentina.
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS England, NICE, the University of Manchester, and Bangor University.
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
We know that immunisation pays off: the wider societal benefits of childhood immunisation programmes in low and middle income countries outweigh their costs up to 51 times while…
Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order
2 June 2025
This is the first in a series of OHE Insights on the history, implications and possible impact of President Trump’s Executive Order on a “Most Favoured Nation” (MFN) pricing model for pharmaceuticals.